Ressources

Interroger le portail de données probantes de l’ACMTS sur la COVID‑19 Examen d’une technologie de la santé de l’ACMTS : le sotrovimab dans le traitement de la COVID-19

Product: — Canadian Agency for Drugs and Technologies in Health

Drug Interventions Infectious Diseases & Clinical Care Treatments

covid.cadth.ca Dernière mise à jour: septembre 15, 2021

Also available in English

Understanding the Post COVID‑19 Condition (Long COVID) and the Expected Burden for Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Dernière mise à jour: septembre 14, 2021

The Incidence, Severity, and Management of COVID‑19 in Critically Ill Pregnant Individuals

Product: — Science Table

Infectious Diseases & Clinical Care

Dernière mise à jour: septembre 13, 2021

The Impact of the COVID‑19 Pandemic on Opioid-Related Harm in Ontario

Product: — Science Table

Infectious Diseases & Clinical Care

Dernière mise à jour: septembre 8, 2021

Heparin Anticoagulation for Hospitalized Patients with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care

Dernière mise à jour: septembre 3, 2021

Update on COVID‑19 Projections

Product: — Science Table

Epidemiology Public Health & Implementation

Dernière mise à jour: septembre 1, 2021

COVID-19 Vaccine Certificates: Key Considerations for the Ontario Context

Product: — Science Table

Public Health & Implementation Public Health Policy Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: juillet 21, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: juin 15, 2021

Response to the Premier of Ontario

Product: — Science Table

Community & Social Services Future Planning Public Health & Implementation Public Health Policy Public Policy & Economic Impact

covid19-sciencetable.ca Dernière mise à jour: mai 29, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Dernière mise à jour: mai 11, 2021